Dual-hormone metabolic medicine
A medicine that acts on two gut-hormone receptors at once — GLP-1 and GIP — rather than one.
Form: 15 / 30 / 60 mg · 3 mL vial · lyophilized
Commonly used for
- Weight-management programs
- Appetite and metabolic goals
What the research covers
A randomised phase 3 trial in adults with type 2 diabetes focused on blood-sugar control and also reported adverse effects, including digestive ones.
- Frías et al., 2021 — SURPASS-2, randomised phase 3 — N Engl J Med
Questions to ask your provider
- Am I a candidate, and what would rule me out?
- How is the dose stepped up, and what does each step feel like?
Educational information only — not medical advice. Eligibility and treatment decisions are made by a licensed medical provider. Results vary and are not guaranteed.
Compounded medications are not FDA-approved or evaluated by FDA for safety, effectiveness, or quality.